Showing 1 - 9 results of 9 for search 'Sabrin R. M. Ibrahim', query time: 0.02s
Refine Results
-
1
-
2
Exploring Novel Y140F/H Mutant Fungal CYP51 Inhibitors: A Molecular Docking and Dynamics Study on Thiophene Compounds by Abdulrahim A. Alzain, Alaa Edris, Rua M. Mukhtar, Hagar M. Mohamed, Malek Abdullah Marzoqi Aldowimar, Ali A. Alqarni, Gamal A. Mohamed, Sabrin R. M. Ibrahim
Published 2025-06-01Get full text
Article -
3
Computational screening campaign reveal natural candidates as potential ASK1 inhibitors: Pharmacophore modeling, molecular docking, MMGBSA calculations, ADMET prediction, and molec... by Rayan Yousif, Hagar M. Mohamed, Mohammed A. Almogaddam, Khaled M. Elamin, Sabrin R.M. Ibrahim, Bayan E. Ainousah, Ahmed Mohammad Alraddadi, Ehda Ahmad Awad, Abdulrahim A. Alzain
Published 2025-06-01Get full text
Article -
4
6-Paradol mitigates rotenone-induced Parkinson’s disease via shutting TNFR-1/RIPK1/RIPK3/MLKL cascade and enhancement of PPARγ/PGC-1α/TFAM axis by Alaa Sirwi, Mostafa A. Rabie, Abdulrahman E. Koshak, Dina A. I. Albadawi, Ali M. El-Halawany, Sabrin R. M. Ibrahim, Gamal A. Mohamed, Hossam M. Abdallah, Nesrine S. El-Sayed
Published 2025-06-01Get full text
Article -
5
α-Glucosidase, butyrylcholinesterase and acetylcholinesterase inhibitory activities of phenolic compounds from Carthamus tinctorius L. flowers: In silico and in vitro studies by Jawaher A.M. Alotaibi, Alaa Sirwi, Ali M. El-Halawany, Ahmed Esmat, Gamal A. Mohamed, Sabrin R.M. Ibrahim, Abdulrahim A. Alzain, Taher F. Halawa, Martin Safo, Hossam M. Abdallah
Published 2024-07-01Get full text
Article -
6
Allopurinol as cardioprotective agent in chronic coronary syndrome: In silico evaluation of its potential as Keap1/Nrf2 modulator by Kannan O. Ahmed, Mohammed A. Almogaddam, Hagar M. Mohamed, Bayan E. Ainousah, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Nawal A. Alharbi, Toga K. Mohamed, Bashir A. Yousef, Khalid Al Balushi, Abdulrahim A. Alzain
Published 2025-06-01Get full text
Article -
7
Molecular Docking, Molecular Dynamics Simulation, and Pharmacophore-Based Virtual Screening Unveil Natural Compounds with TIM-3 Inhibitory Activity by Abdulrahim A. Alzain, Mohammed A. Almogaddam, Rayan Yousif, Mohammed Hamed Alqarni, Ahmed I. Foudah, Wadah Osman, Khaled M. Elamin, Hagar M. Mohamed, Ehssan Moglad, Ahmed Ashour, Reham M. Samra, Gamal A. Mohamed, Sabrin R.M. Ibrahim
Published 2025-06-01Get full text
Article -
8
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies. by Tagyedeen H Shoaib, Walaa Ibraheem, Mohammed Abdelrahman, Wadah Osman, Asmaa E Sherif, Ahmed Ashour, Sabrin R M Ibrahim, Kholoud F Ghazawi, Samar F Miski, Sara A Almadani, Duaa Fahad ALsiyud, Gamal A Mohamed, Abdulrahim A Alzain
Published 2023-01-01Get full text
Article -
9
Screening Enamine Fragments Library in the Quest for Novel SOS2 Inhibitors: Pharmacophore Modelling, Molecular Docking, MMGBSA Calculations, and MD Simulation by Abdulrahim A. Alzain, Mohammed A. Almogaddam, Alaa A. Makki, Alaa Edris, Hagar M. Mohamed, Sitelbanat Y. Ehaimir, Shaimaa G. A. Mohamed, Sarah Ameen Taher Felemban, Wedad Hamad Hammad Alshammari, Gamal A. Mohamed, Sabrin R. M. Ibrahim
Published 2025-06-01Get full text
Article